Page last updated: 2024-08-22

lutetium and Blood Diseases

lutetium has been researched along with Blood Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahmadzadehfar, H; Bartenstein, P; Baum, RP; Bögemann, M; Brenner, W; Drzezga, A; Essler, M; Eveslage, M; Fendler, WP; Haberkorn, U; Heinzel, A; Heuschkel, M; Kratochwil, C; Krause, BJ; Kulkarni, HR; Luster, M; Lützen, U; Marx, M; Meyer, PT; Mottaghy, FM; Pfestroff, A; Prasad, V; Rahbar, K; Ruf, J; Schäfers, M; Schmidt, M	1

Other Studies

1 other study(ies) available for lutetium and Blood Diseases

Article	Year
German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017, Volume: 58, Issue:1 Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Causality; Comorbidity; Dipeptides; Germany; Hematologic Diseases; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Male; Middle Aged; Prevalence; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Injuries; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Treatment Outcome	2017

Article

Year

German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017, Volume: 58, Issue:1

Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Causality; Comorbidity; Dipeptides; Germany; Hematologic Diseases; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Male; Middle Aged; Prevalence; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Injuries; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Treatment Outcome

2017